Tag "FDA"

FDA Approves Drug That Could Take A Slice Out Of J&J Best Seller

FDA Approves Drug That Could Take A Slice Out Of J&J Best Seller (0)

Pharma giant Johnson & Johnson's Remicade brought in nearly $7 billion in sales last year. But Samsung Bioepis and partner Merck are hoping to claw away some of that market share with a new rival therapy—one that could come at a significant discount to the pricey arthritis and psoriasis treatment, which is J&J's best-selling product by far.
FDA cracks down on ‘illegal’ cancer treatments

FDA cracks down on ‘illegal’ cancer treatments (2)

The US FDA calls it "cruel deception": companies promising desperate consumers that their products can cure cancer. On Tuesday, the agency responsible for policing the American food and drug market issued warning letters to 14 companies that it says are "illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer."
Opioid Epidemic Is FDA’s Top Priority Says Scott Gottlieb

Opioid Epidemic Is FDA’s Top Priority Says Scott Gottlieb (0)

Opioid painkillers that have led to thousands of deaths and new drug addicts should be the highest priority of the U.S. FDA, said Scott Gottlieb, President Donald Trump’s pick to lead the agency.
Trump’s Nominee To Head The FDA Got Paid Millions By The Health Care Industry

Trump’s Nominee To Head The FDA Got Paid Millions By The Health Care Industry (0)

Dr. Scott Gottlieb, President Donald Trump's nominee to head the FDA, is a widely respected physician and prominent conservative health care thinker. He also has some serious financial ties to the industry he's tasked with overseeing if ultimately confirmed by the Senate. Gottlieb has received millions of dollars in compensation from some 20-odd biopharma and health firms, according to financial disclosure documents reported by the Wall Street Journal.
The FDA Just Approved the First Ever Drug to Treat Severe MS

The FDA Just Approved the First Ever Drug to Treat Severe MS (0)

Late Tuesday, the FDA approved a groundbreaking multiple sclerosis treatment from Roche/Genentech—the first one ever approved to treat a severe form of MS called primary progressive multiple sclerosis (PPMS).
Trump Is Slashing FDA Rules. Why Isn’t Big Pharma Excited?

Trump Is Slashing FDA Rules. Why Isn’t Big Pharma Excited? (0)

President Donald Trump is planning to take the ax to Food and Drug Administration regulations. “[We’re] going to be streamlining the process so that, from your standpoint, when you have a drug, you can actually get it approved instead of waiting for many, many years,” he told a collection of Big Pharma CEOs, including the chief executives of Merck, Novartis and Johnson & Johnson, during a White House meeting earlier this year.
The Opportunities And Challenges Of AI In Health Care

The Opportunities And Challenges Of AI In Health Care (0)

When we asked dozens of venture capitalists where they see the most potential for applied artificial intelligence, they unanimously agreed on health care. Technology has already been used to incrementally improve patient medical records, care delivery, diagnostic accuracy, and drug development, but with AI we could achieve exponential breakthroughs.
Trump Wants To Shutter The FDA, But Does Anyone Really Want This?

Trump Wants To Shutter The FDA, But Does Anyone Really Want This? (3)

President Donald Trump wants to remake the Food and Drug Administration. And he happens to have a “fantastic person” in mind to do it, he said Tuesday — someone who will turn the agency into an industry-friendly shop that cranks out new cures on the double.
Trump Wants The FDA To Move Faster. His Actions Are Having The Opposite Effect.

Trump Wants The FDA To Move Faster. His Actions Are Having The Opposite Effect. (0)

“It doesn’t help if there’s chaos, demoralization, and demonization of the agency.”
FDA approves Amgen drug for secondary hyperparathyroidism

FDA approves Amgen drug for secondary hyperparathyroidism (0)

The U.S. Food and Drug Administration has approved Amgen Inc's treatment for secondary hyperparathyroidism in adult patients with chronic kidney disease undergoing dialysis, the U.S. biotech company said on Tuesday.